Where does Bioverativ Therapeutics Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bioverativ Therapeutics Inc. ranks #4,606 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bioverativ Therapeutics Inc. hold?

Bioverativ Therapeutics Inc. holds 76 US utility patents granted between 2017 and 2025, spanning 21 technology areas.

What is Bioverativ Therapeutics Inc.'s Innovation Score?

Bioverativ Therapeutics Inc. has an Innovation Score of 48.9 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bioverativ Therapeutics Inc. focus on?

Bioverativ Therapeutics Inc.'s top technology area is C07K (Peptides) with 60 patents. Grants appear in 21 CPC subclasses total.

Is Bioverativ Therapeutics Inc.'s patent grant rate increasing or decreasing?

Bioverativ Therapeutics Inc.'s recent grant velocity is +76% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Bioverativ Therapeutics Inc.'s patents?

Bioverativ Therapeutics Inc.'s patents average 23.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bioverativ Therapeutics Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bioverativ Therapeutics Inc.

USPTO PatentsView assignee record - 76 granted patents across 21 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bioverativ ranks #4,606 of 49,997 tracked US assignees by granted-patent volume, with 76 patents across 21 technology areas.

#4,606
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.9/100): 23.0
avg claims per patent: +76%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4606 · US Corporation #4,606 · 76 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 76 grants
TOP-DECILE #4,606/49,997
PHOTO-FINISH Aleddra
CPC-FOCUS C07K · 21 areas
INNOV-PAR 48.9/100
CLAIMS-DENSE 23.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +76% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aleddra Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Alpha EC Industries… · near

49
Bioverativ Therapeut… · this assignee

49
Hannibal IP · near

49
Max-Delbrück-Centrum… · near

49
Production Resource… · near

49
3D Lighting… · lowest

7

What this shows Bioverativ's Innovation Score is 48.9/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Bioverativ's grants concentrate

Bioverativ Therapeutics Inc. is a focused PatentsView assignee: 21 CPC subclasses with 78.9% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (12 grants) versus a trough of 6 in 2023. By volume, Bioverativ sits between Aleddra Inc. and Caterpillar Global Mining LLC.

Bioverativ's three-year grant acceleration

From 2019–2021 to 2022–2024, Bioverativ Therapeutics Inc. moved from 34 to 20 grants (0.59x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Aleddra

76
Aurrion

76
Autonomous Soluti…

76
Biotix

76
Berkshire Grey

76
Bottomline

76
Cascades Canada U…

76
Caterpillar Globa…

76
Bioverativ Therap… ◀

76

What this shows Bioverativ holds 76 patents at rank #4,605, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bioverativ

By rank, the assignees closest to #4,605 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Bioverativ's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bioverativ, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Production Resource Group, L.L.C. 49 Hannibal IP LLC 49 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft 49 Alpha EC Industries 2018 S.A.R.L. 49

Similar claim depth

Nearest assignees by average claims per patent (23.0 here).

Location Labs, Inc. 23.0 avg Markforged, Inc 23.0 avg Takeda Vaccines, Inc. 22.9 avg Ionis Pharmaceuticals, Inc. 22.9 avg

Bioverativ's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Bioverativ Therapeutics Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	8	10.5%
2018	7	9.2%
2019	10	13.2%
2020	12	15.8%
2021	12	15.8%
2022	8	10.5%
2023	6	7.9%
2024	6	7.9%
2025partial year	7	9.2%

Which technologies does Bioverativ Therapeutics Inc. patent most?

C07K - Peptides 60

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 57

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 50

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 39

C12Y - Enzymes 31

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

F26B - Drying Solid Materials OR Objects BY Removing Liquid Therefrom 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 15 of 21 technology areas

Where it ranks

Overall rank by patents

#4,606

of 49,997 tracked assignees

Innovation Score

48.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Bioverativ Therapeutics Inc.'s patent record in context - here's where to go next.

Bioverativ Therapeutics Inc.'s lead technology class is C07K (Peptides), 78.9% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #4,606 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bioverativ Therapeutics Inc. against Aleddra Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.